Introduction
Evidence-based medicine aims to translate scientifi c research into good medical practice. The Royal College of Obstetricians and Gynaecologists publishes recommendations and guidelines to guide clinicians in decision-making. In this study, the evidence base underlying the ' Green-top Guidelines ' has been analysed in order to establish the quality of research underlying recommendations. During this descriptive study of 1,682 individual recommendations, the authors found that only 9 -12% of the guidelines were based on the best quality (Grade A) evidence. The authors believe that this type of analysis serves to provide greater clarity for clinicians and patients using guidelines and recommendations in the fi eld of obstetrics and gynaecology to make collaborative clinical decisions.
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Th ere have been no previous analyses of the overall evidence underlying the Royal College of Obstetricians and Gynaecologists (RCOG) guidelines. However, a study by Wright in 2011 found that only one-third of the recommendations by the American College of Obstetricians and Gynecologists were based on good scientifi c evidence (Wright et al. 2011) . In similar studies, this was the case in 14% of the recommendations by the Infectious Diseases Society of America (Lee and Vielemeyer 2011) , and 45% of cardiovascular risk recommendations from guidelines across the USA, Canada and Europe (McAlister et al. 2007) .
Th e objective of this study was to analyse the evidence used in guidelines published by the RCOG and to identify areas where evidence is high-quality, adequate or lacking. It is important to be aware of the standard of evidence which underpins the advice which doctors access for the diagnosis and management of their patients.
Materials and methods
Th e Royal College of Obstetricians and Gynaecologists produces a large number of guidelines for the management and diagnosis of a wide variety of diseases and conditions. Th e College produces diff erent categories of advice: ' Consent Advice ' , ' Good Practice ' , ' Joint Guidelines ' , ' National Evidence Based Guidelines ' and ' Project Reports ' , among others. For the purpose of this analysis, we used the ' Green-top Guidelines ' . Each Green-top Guideline addresses a specifi c topic, giving a brief introduction to the subject in question and detailing how the supporting evidence was obtained. For the guidelines included, see Table I . Th e guidelines themselves include a series of recommendations, each graded by the overall quality of supporting evidence, the details of which are included in Table II . In addition, the studies and trials cited in support of the recommendations made were further classifi ed using a numerical system, which has not been included for simplifi cation. Th e method of grading of recommendations and classifi cation of evidence was changed in December 2007. For this reason, guidelines created before that date and guidelines created aft er that date were analysed separately to avoid the introduction of any bias or subjectivity into classifi cation.
All 52 ' Green-top Guidelines ' were obtained from the Royal College of Obstetricians and Gynaecologists ' website on 1 April 2012. One guideline (Green-top 31, ' Small-for-Gestational-Age Fetus, Investigation and Management ' , published on 1 November 2002) was not included in the analysis, as its evidence levels were classifi ed using a diff erent system from the others. Two guidelines have been archived by the RCOG (Green-tops 10A and 35), with advice to refer to the appropriate National Institute of Clinical Excellence (NICE) guidelines for assistance, and therefore could not be obtained or included in analysis. RCOG Green-top guidelines published before December 2007 are classifi ed according to one of four levels of evidence: A (literature of overall good quality and evidence); B (well controlled clinical studies); C (evidence from expert committee reports or opinions) and √ (recommended best practice based on the clinical experience of the guideline development group). Th ose issued from December 2007 were classifi ed using a fi ve-tiered system: A (meta-analysis, systematic review or a good quality randomised controlled trial); B (high quality systematic reviews of case -control or cohort studies); C (high quality case -control or cohort studies with a low risk of confounding); D (nonanalytical studies, such as case reports/expert opinion) and √ (recommended best practice based on the clinical experience of the guideline group).
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We gathered the grades of each recommendation within each guideline, and then stratifi ed each guideline into those primarily focussed on obstetrics and those primarily focussed A At least one meta-analysis, systematic review or randomised controlled trial rated as 1 ϩ ϩ directly applicable to the target population and demonstrating overall consistency of results. A systematic review of randomised controlled trials or a body of evidence consisting principally of studies rated as 1 ϩ directly applicable to the target population and demonstrating overall consistency of results. B A body of evidence including studies rated as 2 ϩ ϩ directly applicable to the target population, and demonstrating overall consistency of results. Extrapolated evidence from studies rated as 1 ϩ ϩ or 1 ϩ . C A body of evidence including studies rated as 2 ϩ directly applicable to the target population and demonstrating overall consistency of results. Extrapolated evidence from studies rated as 2 ϩ ϩ . D Evidence level 3 or 4. Extrapolated evidence from studies rated as 2 ϩ . E Recommended best practice based on the clinical experience of the guideline development group.
on gynaecology. We then sub-divided the latter into the following: General Gynaecology, Oncology, Fertility and Endoscopy. In addition to this, we sorted the guidelines based on whether they referred to Evaluation, Diagnosis and Treatment, or Mode of Delivery (Table III) . Th is was carried out independently by three reviewers; categorisations were then discussed and any discrepancies were resolved by consensus (majority opinion of all the reviewers). Descriptive statistics were then used to report the fi ndings of this analysis. Th e Research Management and Governance Department at the Whittington Hospital, UK, agreed that the project did not require NHS ethics approval. 
Results
A total of 52 guidelines that off ered 1,682 individual recommendations were studied (Table I) ; 32 of the guidelines were obstetric (61.5%) and 20 were gynaecological (38.5%). Within these guidelines, 1,160 (69%) of the individual recommendations were obstetric and 522 (31%) were gynaecological. Of the recommendations published before December 2007, 52 (12%) referenced level A evidence; 94 (22%) level B evidence; 126 (29%) level C evidence; and 163 (37%) were based on recommended best practice ( Figure 1a ). Regarding guidelines published from December 2007 onwards, 114 (9%) were based on level A evidence; 145 (12%) level B; 210 (17%) level C; 276 (22%) level D and 502 (40%) were recommended best practice (Figure 1b) . Th is suggests that, contrary to the aims of evidence-based medicine, guidelines published more recently are actually more likely to be based on clinical experience alone. However, since the new classifi cation system places more stringent measures on evidence that can qualify as level A, the two sub-sets cannot be directly compared. Within the two classifi cation systems (that used prior to December 2007 and that used aft er), the distribution of quality of evidence was divided into that supporting obstetric guidelines and that supporting gynaecological guidelines. Among the obstetric recommendations published under the old system, 22 (8%) provided level A evidence; 48 (18%) level B; 89 (33%) level C and 111 (41%) were recommended best practice (Figure 2a) . Of those published aft er December 2007, using the new fi ve-tiered system, 69 (8%) provided level A evidence; 93 (10%) level B; 147 (16%) level C; 229 (26%) level D and 352 (40%) were recommended best practice (Figure 2b ). Th is suggests there has been no signifi cant change in the quality of sources of evidence used by the RCOG to write obstetric guidelines over the past few years, and that the greater reliance of more recently published guidelines by the RCOG on clinical experience alone is due to the newer gynaecological rather than obstetric guidelines.
Among the gynaecological recommendations published before December 2007, 30 (18%) were based on level A evidence; 46 (28%) level B; 37 (22%) level C and 52 (32%) were recommended best practice (Figure 3a) . In those published post-December 2007, (Figure 3b ). Th is demonstrates that across all guidelines (regardless of publication date), those concerned with gynaecology had a higher quality of underlying evidence than obstetric guidelines, with greater numbers based on the fi ndings of metaanalyses and well-conducted randomised controlled trials.
Royal College of Obstetricians and Gynaecologists guidelines 709
Th e recommendations were then further stratifi ed by our classifi cation scheme. Within obstetrics, 68.8% of recommendations addressed diagnosis and treatment; 12.5% evaluation and 18.8% mode of delivery. Within gynaecology, 85% of recommendations addressed diagnosis and treatment and 15% evaluation. Once again, those published under each of the two classifi cation systems had to be evaluated separately. Of the obstetric guidelines published under the old system, 5.6% of guidelines concerning evaluation were based on level A treatment, compared with 6.4% of diagnosis and treatment, and 12.5% of mode of delivery recommendations (Figure 4a ). Of the newer obstetric guidelines, 6.4% of evaluation, 8.1% of diagnosis and treatment and 7.4% of mode of delivery recommendations were based on level A evidence (Figure 4b ).
Of the older gynaecological guidelines, 14.3% of evaluative and 18.8% of diagnostic and treatment recommendations were based on level A evidence (Figure 5a ), compared with 0% of evaluative and 15.1% of diagnostic and treatment recommendations published under the new classifi cation system (Figure 5b) .
Th e 20 gynaecology guidelines were further categorised by subspecialty; the majority (70%) addressed general gynaecology issues; 20% were concerned with fertility; 5% with oncology and 5% with endoscopy. Th e results showed that 10.8% of fertility guidelines published under the old system and 20.8% of those published more recently, were based on level A evidence, compared with 24.2% and 7.3% of general gynaecology guidelines published before and aft er December 2007, respectively. Th ere was only one guideline related to gynaecological oncology, for which none of the evidence was level A. Conversely, the only endoscopy guideline was based on evidence, of which 42.3% was level A (Figure 6 ).
Overall, the results suggest that the majority of supportive evidence behind the RCOG guidelines is based on clinical expertise or studies defi ned as low quality, and that this does not appear to be changing with new guidelines. Gynaecological guidelines seem to generally have a higher quality evidence base than obstetric recommendations.
Discussion
Th e fi ndings of this guideline analysis suggest that on average across the categories, fewer than 20% of recommendations by the RCOG were based on high quality evidence, with a large proportion based on ' recommended best practice ' and expert opinion. We go on to question why this is so and what this means in an era of evidence-based practice. Th e ' Green-top Guidelines ' reviewed in this study are written and developed by the RCOG to provide systematic recommendations in the hope of assisting clinicians and patients in clinical decision-making. Guideline topics are selected through a process coordinated by the Guidelines and Audit Committee, made up of clinicians, with input from the RCOG Consumers ' Forum. Guidelines are developed by collating evidence and making value judgements by consensus. Th ey must then meet the Appraisal of Guidelines for Research and Evaluation in Europe (AGREE) criteria and are subsequently peer reviewed in a formal, open process. Th e system used by the RCOG to grade the evidence quality is based on the scoring system developed by the ' GRADE Working Group ' (Balsham et al. 2011) . Th is is intended to introduce further rigour into the classifi cation of evidence quality underlying guidelines. However, there is also concern that such a simplistic representation of evidence (stating quality as A, B or C) might not communicate an accurate enough interpretation of quality (Charles et al. 2011 ). Recommendations are not intended to be used exclusively to decide upon a course of management or treatment; instead the clinician ' s judgement should also give equal consideration to individual patient needs and the variation of recourses between institutions (RCOG 2012) .
Th e recent Institute of Medicine report in the USA on the development of guidelines and their worth in modern practice highlights the fact that guidelines can be fl awed in their formation; such fl aws may be due to a lack of transparency in how they are created and rated, and an absence of rigorous external review. Th ey suggest that authors of guideline recommendations should provide a summary of the quality of the evidence they have used (Institute of Medicine, no date).
Research in obstetrics and gynaecology, as in other fi elds (Lee and Vielemeyer 2011; McAlister et al. 2007 ) is clearly lacking in randomised controlled trials. Th is can be put down to several factors. Th e acute nature of the specialty means there are ethical and practical diffi culties that make trial design and implementation impossible (Lee and Vielemeyer 2011) . Some have postulated that practice based on such ' real-life ' observational evidence might be of more value in obstetrics than randomised control trials (Vintzileos 2009 ), however, this evidence would be prone to error and bias. In addition, only a minority of obstetricians conduct a literature search when presented with a clinical dilemma, and personal experience and views of experts still have a far-reaching infl uence over obstetric practice (Olatunbosun et al. 1998) .
It is also important to acknowledge the uniqueness of obstetric practice in relation to its partner, midwifery. Th e ancient tradition and long history of midwifery has its own body of expert opinion, based on historical and research experience, and Th e Royal College of Midwives has its own set of online guidelines, which does not use the GRADE system.
Within the subspecialties of obstetrics and gynaecology, there is a diff erence in quality of supportive evidence; endoscopy, a relatively new intervention in this fi eld, would require evidence to prove its value and would have the fi nancial backing needed to provide this -the sole endoscopy guideline was based on 42.3% level A evidence. However, some Grade C recommendations for established practice can be very useful in a ' common sense ' way. For example, that low risk postpartum women do not need thromboprophylaxis (RCOG 2009 ). Even fundamental cornerstones of clinical practice, such as partograms, are not based on strong evidence. A review of the use of partograms on birth outcomes conducted by the Cochrane Collaboration concluded that they could not recommend the routine use of the partogram as part of standard labour management (Lavender et al. 2008 ). Zhang (2002) also found that the average labour of nulliparous
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women varies markedly from the Friedman curve during the fi rst stage of labour, and as such, it is possible that interventions for slow progression may come too early due to overly strict guidelines (Zhang et al. 2002 ). Yet the partogram remains an important foundation of intrapartum care in the UK. Even when there is supposedly good quality evidence underpinning guidelines, this is sometimes fl awed -a case in point is the issue of caesarean delivery of breech presentations. Th e publication of the Term Breech Trial (Hannah 2000) , a multicentre randomised trial, implied that it was safer to perform a caesarean section at birth for all breech infants, and as such, it was incorporated into guidelines in the USA, UK and Canada. However, a post hoc inquiry into this trial ' s methodology has revealed inconsistencies and errors in data collection and analysis, which make the study ' s fi ndings unreliable (Kotaska 2011) .
We accept that there are several limitations to this study. Th e categorisation system developed was designed to assist us in providing meaningful conclusions. However, the introduction of such rigid parameters may be detrimental to the accuracy of the analysis. Naturally this system is dependent on the reviewer, and other researchers may diff er in their approach to classifi cation. We have modelled our analysis on the study published by Wright et al. (2011) to facilitate meaningful comparison between the two papers.
Th is analysis has revealed that the majority of guideline recommendations were not underpinned by high quality evidence. Th e same sort of discourse is occurring in the basic sciences, as in the New Scientist article: ' Is medical science built on shaky foundations? ' , which raises the point that more than half of biomedical fi ndings cannot be reproduced (Iorns, 2012) . One could ponder the impact of these conclusions that, in both the UK and USA, the majority of practice guidelines are not founded on high quality evidence, and this is refl ected in clinical practice, in science and medicine across the board. We should not dismiss the limitations of the RCOG or ACOG recommendations, but acknowledge them in order to neutralise any assumptions made by clinician or patient that recommendations are based on high quality evidence.
All medical colleges could off er this form of descriptive analytic summary of the quality of evidence their guidelines are based on. Th is would provide greater clarity for clinicians as to the core scientifi c foundations of their clinical practice, as well as serving to aid transparency of speciality knowledge in the clinician -patient partnership of decision-making.
